vs
BIOLIFE SOLUTIONS INC（BLFS）与Maase Inc.（MAAS）财务数据对比。点击上方公司名可切换其他公司
BIOLIFE SOLUTIONS INC的季度营收约是Maase Inc.的1.9倍（$18.8M vs $9.9M）
BIOLIFE SOLUTIONS INC专注于开发生物保存产品及冷链管理解决方案，服务于细胞与基因治疗、生物制药及再生医学领域，产品涵盖低温保存培养基、自动化解冻系统、温度监测工具，为全球相关企业、科研机构及临床实验室提供支持。
BLFS vs MAAS — 直观对比
营收规模更大
BLFS
是对方的1.9倍
$9.9M
损益表 — Q4 FY2025 vs Q2 FY2023
| 指标 | | |
|---|---|---|
| 营收 | $18.8M | $9.9M |
| 净利润 | $11.1M | — |
| 毛利率 | — | 78.7% |
| 营业利润率 | 7.2% | -55.9% |
| 净利率 | 58.9% | — |
| 营收同比 | 24.3% | — |
| 净利润同比 | -11.1% | — |
| 每股收益（稀释后） | $0.23 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BLFSMAAS
| Q4 25 | $18.8M | — | ||
| Q3 25 | $28.1M | — | ||
| Q2 25 | $25.4M | — | ||
| Q1 25 | $23.9M | — | ||
| Q4 24 | $15.1M | — | ||
| Q3 24 | $21.4M | — | ||
| Q2 24 | $19.7M | — | ||
| Q1 24 | $18.4M | — |
净利润BLFSMAAS
| Q4 25 | $11.1M | — | ||
| Q3 25 | $621.0K | — | ||
| Q2 25 | $-15.8M | — | ||
| Q1 25 | $-448.0K | — | ||
| Q4 24 | $12.5M | — | ||
| Q3 24 | $-1.7M | — | ||
| Q2 24 | $-20.7M | — | ||
| Q1 24 | $-10.2M | — |
营业利润率BLFSMAAS
| Q4 25 | 7.2% | — | ||
| Q3 25 | -0.3% | — | ||
| Q2 25 | -65.5% | — | ||
| Q1 25 | -5.1% | — | ||
| Q4 24 | 3.6% | — | ||
| Q3 24 | -2.0% | — | ||
| Q2 24 | -6.6% | — | ||
| Q1 24 | -17.9% | — |
净利率BLFSMAAS
| Q4 25 | 58.9% | — | ||
| Q3 25 | 2.2% | — | ||
| Q2 25 | -62.3% | — | ||
| Q1 25 | -1.9% | — | ||
| Q4 24 | 82.5% | — | ||
| Q3 24 | -8.0% | — | ||
| Q2 24 | -105.1% | — | ||
| Q1 24 | -55.4% | — |
每股收益（稀释后）BLFSMAAS
| Q4 25 | $0.23 | — | ||
| Q3 25 | $0.01 | — | ||
| Q2 25 | $-0.33 | — | ||
| Q1 25 | $-0.01 | — | ||
| Q4 24 | $0.27 | — | ||
| Q3 24 | $-0.04 | — | ||
| Q2 24 | $-0.45 | — | ||
| Q1 24 | $-0.22 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $33.0M | $10.9M |
| 总债务越低越好 | $5.0M | — |
| 股东权益账面价值 | $371.9M | $31.6M |
| 总资产 | $405.9M | $47.0M |
| 负债/权益比越低杠杆越低 | 0.01× | — |
8季度趋势，按日历期对齐
现金及短期投资BLFSMAAS
| Q4 25 | $33.0M | — | ||
| Q3 25 | $29.5M | — | ||
| Q2 25 | $31.9M | — | ||
| Q1 25 | $66.9M | — | ||
| Q4 24 | $91.5M | — | ||
| Q3 24 | $24.0M | — | ||
| Q2 24 | $22.0M | — | ||
| Q1 24 | $29.7M | — |
总债务BLFSMAAS
| Q4 25 | $5.0M | — | ||
| Q3 25 | $7.5M | — | ||
| Q2 25 | $10.1M | — | ||
| Q1 25 | $12.9M | — | ||
| Q4 24 | $15.9M | — | ||
| Q3 24 | $20.1M | — | ||
| Q2 24 | $21.1M | — | ||
| Q1 24 | $24.3M | — |
股东权益BLFSMAAS
| Q4 25 | $371.9M | — | ||
| Q3 25 | $353.7M | — | ||
| Q2 25 | $347.2M | — | ||
| Q1 25 | $352.6M | — | ||
| Q4 24 | $348.9M | — | ||
| Q3 24 | $325.5M | — | ||
| Q2 24 | $321.4M | — | ||
| Q1 24 | $333.4M | — |
总资产BLFSMAAS
| Q4 25 | $405.9M | — | ||
| Q3 25 | $392.1M | — | ||
| Q2 25 | $387.2M | — | ||
| Q1 25 | $395.1M | — | ||
| Q4 24 | $399.5M | — | ||
| Q3 24 | $381.7M | — | ||
| Q2 24 | $375.0M | — | ||
| Q1 24 | $401.6M | — |
负债/权益比BLFSMAAS
| Q4 25 | 0.01× | — | ||
| Q3 25 | 0.02× | — | ||
| Q2 25 | 0.03× | — | ||
| Q1 25 | 0.04× | — | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | 0.06× | — | ||
| Q2 24 | 0.07× | — | ||
| Q1 24 | 0.07× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.9M | $-18.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-18.3M |
| 自由现金流率自由现金流/营收 | — | -184.4% |
| 资本支出强度资本支出/营收 | — | 1.0% |
| 现金转化率经营现金流/净利润 | 0.44× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流BLFSMAAS
| Q4 25 | $4.9M | — | ||
| Q3 25 | $6.1M | — | ||
| Q2 25 | $7.4M | — | ||
| Q1 25 | $1.7M | — | ||
| Q4 24 | $1.6M | — | ||
| Q3 24 | $4.8M | — | ||
| Q2 24 | $6.5M | — | ||
| Q1 24 | $-4.5M | — |
现金转化率BLFSMAAS
| Q4 25 | 0.44× | — | ||
| Q3 25 | 9.83× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.13× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BLFS
暂无分部数据
MAAS
| Wealth management | $7.8M | 78% |
| Insurance consulting | $1.0M | 10% |
| Other | $975.0K | 10% |
| Asset management | $168.0K | 2% |
